EBEmine Kubra Bilir

Emine Kubra Bilir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emine Kubra Bilir has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Riboflavin Attenuates High-Fructose Corn Syrup Induced Ocular Injury Through Modulation of Redox, Inflammation and Barrier-Associated Responses

    by Alper Ertugrul, Halil Asci, Gülşah Usta Sofu, Dudu Seher Yurt, Cansu Karacolak, Emine Kubra Bilir, Özlem Özmen

    High-fructose corn syrup (HFCS) consumption has been associated with oxidative stress-related tissue injury; however, its effects on ocular tissues remain poorly understood. This study investigated the protective effects of riboflavin (RIB) against HFCS-induced ocular injury. Thirty-two male Wistar albino rats were randomly assigned to four groups (n = 8/group): Control, HFCS (30% in drinking water), HFCS + RIB (25 mg/kg/day, oral gavage), and RIB. Following the experimental period, ocular tissues were collected for histopathological evaluation of the cornea, limbus, retina, and lens. Corneal and retinal thickness were measured morphometrically. Immunohistochemical analyses of nuclear factor kappa B (NF-κB) and caspase 3 were conducted to assess inflammatory and apoptotic responses. Gene expression levels of glutathione peroxidase 4 (GPX4), heme oxygenase-1 (HO-1), hypoxia-inducible factor 1-alpha (HIF-1α), interleukin 6 (IL-6), NLR family pyrin domain-containing 3 (NLRP3), Beclin-1, caspase 3 (CASP-3), aquaporin 4 (AQP4) and zonula occludens-1 (ZO-1) were quantified by reverse transcription quantitative polymerase chain reaction. HFCS exposure induced significant histopathological alterations, increased corneal and retinal thickness, enhanced NF-κB and caspase-3 immunoreactivity, upregulated NLRP3, Beclin-1, CASP-3, and AQP4 expression, and reduced GPX4, HO-1, and HIF-1α expression. RIB administration significantly attenuated these pathological and molecular alterations. In conclusion, RIB attenuated HFCS-associated structural ocular injury and favorably modulated the expression of genes related to antioxidant defense, inflammatory signaling, cellular stress responses, apoptosis, and barrier-associated homeostasis. These findings support a potential protective role for RIB against diet-associated ocular injury.

  • Open Access

    In Vitro Ocular Cytotoxicity of BEE Venom in ARPE-19, NTM5, HCET, and HCEC-12 Cell Lines

    by Emine Kubra Bilir, Hidayet Tutun, Sedat Sevin, Şeyda Kıvrak, Tommaso Bucci, Rachel Williams

    Bee venom (BV) is a complex natural secretion of Apis mellifera with documented anti-inflammatory, antimicrobial, and anticancer properties. Despite its therapeutic potential, safety concerns remain due to its strong cytotoxic effects, particularly in sensitive tissues such as the eye. In this study, we evaluated the composition and ocular cytotoxicity of purified BV obtained from the Muğla ecotype of Apis mellifera anatoliaca . High-performance liquid chromatography with variable wavelength detection (HPLC-VWD) confirmed the presence of three principal components; melittin (71.08 ± 0.33%), phospholipase A₂ (12.98 ± 0.27%), and apamin (3.02 ± 0.25%) at retention times consistent with reference standards. Cytotoxicity was assessed in four human ocular cell lines: ARPE-19 (retinal pigment epithelium), NTM5 (trabecular meshwork), HCE-T (corneal epithelium), and HCEC-12 (corneal endothelium), using MTT viability assays and live/dead staining over 24 h and 48 h. BV exerted strong, dose and time dependent cytotoxic effects across all cell lines, with ARPE-19 and NTM5 cells exhibiting the highest sensitivity. IC₅₀ values were 22.36 µg/mL (24 h) and 12.55 µg/mL (48 h) in ARPE-19, and 20.78 µg/mL (24 h) and 13.07 µg/mL (48 h) in NTM5 cells. By contrast, HCEC-12 and HCE-T cells displayed moderate sensitivity, with IC₅₀ values between 29 and 34 µg/mL. These findings highlight tissue-specific differences in BV susceptibility. While BV may offer therapeutic promise, its narrow safety margin in ocular cells underscores the importance of controlled delivery strategies to minimize toxicity. This study provides foundational data for evaluating the ocular safety profile of BV and informs future translational applications.